Curis Doses First Five Patients in TakeAim CLL Study

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/31/2026

1. AMZN
2. AAPL
3. RBLX
4. RDDT
5. COIN
6. NBIX
7. DXCM
8. GH
9. GDDY
10. WU

Go back to Curis Doses First Five Patients in TakeAim CLL Study
Curis, Inc. (NASDAQ: CRIS) Delayed: 5.00 +0.04 (0.81%)
Previous Close $4.96    52 Week High $3.70 
Open $5.00    52 Week Low $1.25 
Day High $5.17    P/E N/A 
Day Low $4.92    EPS $-0.15 
Volume 12,616